Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries CLASS ACTION UPDATE for PHG, SLQT and ANVS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders By: Levi & Korsinsky, LLP via AccessWire September 13, 2021 at 10:30 AM EDT NEW YORK, NY / ACCESSWIRE / September 13, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.PHG Shareholders Click Here: https://www.zlk.com/pslra-1/koninklijke-philips-n-v-loss-submission-form?prid=19528&wire=1SLQT Shareholders Click Here: https://www.zlk.com/pslra-1/selectquote-inc-loss-submission-form?prid=19528&wire=1ANVS Shareholders Click Here: https://www.zlk.com/pslra-1/annovis-bio-inc-loss-submission-form?prid=19528&wire=1 * ADDITIONAL INFORMATION BELOW *Koninklijke Philips N.V. (NYSE:PHG)PHG Lawsuit on behalf of: investors who purchased February 25, 2020 - June 11, 2021Lead Plaintiff Deadline: October 15, 2021TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/koninklijke-philips-n-v-loss-submission-form?prid=19528&wire=1According to the filed complaint, during the class period, Koninklijke Philips N.V. made materially false and/or misleading statements and/or failed to disclose that: (i) Philips had deficient product manufacturing controls or procedures; (ii) as a result, the Company's Bi-Level PAP and CPAP devices and mechanical ventilators were manufactured using hazardous materials; (iii) accordingly, the Company's sales revenues from the foregoing products were unsustainable; (iv) the foregoing also subjected the Company to a substantial risk of a product recall, in addition to potential legal and/or regulatory action; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.Selectquote, Inc. (NYSE:SLQT)SLQT Lawsuit on behalf of: investors who purchased February 8, 2021 - May 11, 2021Lead Plaintiff Deadline: October 15, 2021TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/selectquote-inc-loss-submission-form?prid=19528&wire=1According to the filed complaint, during the class period, Selectquote, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) SelectQuote's 2019 cohort was underperforming; (2) as a result, the Company's financial results would be adversely impacted; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. Annovis Bio, Inc. (NYSE:ANVS)ANVS Lawsuit on behalf of: investors who purchased May 21, 2021 - July 28, 2021Lead Plaintiff Deadline: October 18, 2021TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/annovis-bio-inc-loss-submission-form?prid=19528&wire=1 According to the filed complaint, during the class period, Annovis Bio, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Annovis's ANVS401 (Posiphen), an orally administrated drug which purportedly inhibited the synthesis of neurotoxic proteins that are the main cause of neurodegeneration, did not show statistically significant results across two patient populations as to factors such as orientation, judgement, and problem solving; and (2) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.CONTACT:Levi & Korsinsky, LLPJoseph E. Levi, Esq.Eduard Korsinsky, Esq.55 Broadway, 10th FloorNew York, NY 10006jlevi@levikorsinsky.comTel: (212) 363-7500Fax: (212) 363-7171www.zlk.comSOURCE: Levi & Korsinsky, LLPView source version on accesswire.com: https://www.accesswire.com/663728/CLASS-ACTION-UPDATE-for-PHG-SLQT-and-ANVS-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
CLASS ACTION UPDATE for PHG, SLQT and ANVS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders By: Levi & Korsinsky, LLP via AccessWire September 13, 2021 at 10:30 AM EDT NEW YORK, NY / ACCESSWIRE / September 13, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.PHG Shareholders Click Here: https://www.zlk.com/pslra-1/koninklijke-philips-n-v-loss-submission-form?prid=19528&wire=1SLQT Shareholders Click Here: https://www.zlk.com/pslra-1/selectquote-inc-loss-submission-form?prid=19528&wire=1ANVS Shareholders Click Here: https://www.zlk.com/pslra-1/annovis-bio-inc-loss-submission-form?prid=19528&wire=1 * ADDITIONAL INFORMATION BELOW *Koninklijke Philips N.V. (NYSE:PHG)PHG Lawsuit on behalf of: investors who purchased February 25, 2020 - June 11, 2021Lead Plaintiff Deadline: October 15, 2021TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/koninklijke-philips-n-v-loss-submission-form?prid=19528&wire=1According to the filed complaint, during the class period, Koninklijke Philips N.V. made materially false and/or misleading statements and/or failed to disclose that: (i) Philips had deficient product manufacturing controls or procedures; (ii) as a result, the Company's Bi-Level PAP and CPAP devices and mechanical ventilators were manufactured using hazardous materials; (iii) accordingly, the Company's sales revenues from the foregoing products were unsustainable; (iv) the foregoing also subjected the Company to a substantial risk of a product recall, in addition to potential legal and/or regulatory action; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.Selectquote, Inc. (NYSE:SLQT)SLQT Lawsuit on behalf of: investors who purchased February 8, 2021 - May 11, 2021Lead Plaintiff Deadline: October 15, 2021TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/selectquote-inc-loss-submission-form?prid=19528&wire=1According to the filed complaint, during the class period, Selectquote, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) SelectQuote's 2019 cohort was underperforming; (2) as a result, the Company's financial results would be adversely impacted; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. Annovis Bio, Inc. (NYSE:ANVS)ANVS Lawsuit on behalf of: investors who purchased May 21, 2021 - July 28, 2021Lead Plaintiff Deadline: October 18, 2021TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/annovis-bio-inc-loss-submission-form?prid=19528&wire=1 According to the filed complaint, during the class period, Annovis Bio, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Annovis's ANVS401 (Posiphen), an orally administrated drug which purportedly inhibited the synthesis of neurotoxic proteins that are the main cause of neurodegeneration, did not show statistically significant results across two patient populations as to factors such as orientation, judgement, and problem solving; and (2) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.CONTACT:Levi & Korsinsky, LLPJoseph E. Levi, Esq.Eduard Korsinsky, Esq.55 Broadway, 10th FloorNew York, NY 10006jlevi@levikorsinsky.comTel: (212) 363-7500Fax: (212) 363-7171www.zlk.comSOURCE: Levi & Korsinsky, LLPView source version on accesswire.com: https://www.accesswire.com/663728/CLASS-ACTION-UPDATE-for-PHG-SLQT-and-ANVS-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders